Sulfachloropyridazine
Sodium Market by Patient Type (Cows, Pigs, Chickens, Cattles, and
Pediatrics), and by Region (North America, Europe, Asia Pacific, Latin America,
Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018
– 2026
Sulfachloropyridazine sodium is a
sulfonamide antibiotic used to study kinetics and reaction pathways. Also, it
is used to treat acute Urinary Tract Infections (UTIs) in pediatric patients.
Sulfachloropyridazine sodium blocks the synthesis of dihydrofolic acid by
inhibiting the enzyme dihydropteroate synthase and bacterial Para-Amino Benzoic
Acid (PABA), which is required for bacterial growth. The compound
Sulfachloropyridazine sodium powder has a curative effect for various animals
with pasteurellosis and is popular for use in animal husbandry.
Sulfachloropyridazine Sodium
Market Drivers
Rising use of antibiotics in
animals to treat certain infections is expected to drive growth of the
sulfachloropyridazine sodium market. For instance, according to an article
published in journal Science, 2017, almost 80% of all antibiotics in the U.S.
are administered to cows, pigs, and chickens to keep them healthy and accelerate
their growth and development.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2263
Moreover, according to the
Louisiana Department of Health, U.S., due
to low cost
and relatively better efficacy against many common bacterial
infections, sulfonamides are some
of the most common antibacterial agents utilized in
veterinary medicine, which is in turn is boosting growth of the sulfachloropyridazine
sodium market.
Sulfachloropyridazine Sodium
Market Restraint
Over the years, bacterial
pathogens have acquired resistance to sulfonamide class of antibiotics, due to
mutations in pre-existing DNA or by acquisition of Antibiotic Resistance Genes
(ARGs), which is expected to hinder growth of the sulfachloropyridazine sodium
market. For instance, according to an article published in journal Microbiome,
2017, use of sulfonamide class of antibiotics is restricted to topical use only
extensively for animals. For instance,
in the U.S., around 380,186 kg of sulfonamides was distributed legally during
2015, to increase the resistance power of food-producing animals. Hence,
further spread of sulfonamide resistance would have hamper the market particularly
in the animal sector.
Sulfachloropyridazine Sodium
Market – Regional Analysis
On the basis of region, the
global sulfachloropyridazine sodium market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/sulfachloropyridazine-sodium-market-2263
North America region is expected
to gain maximum share in the sulfachloropyridazine sodium market, owing to high
prevalence of Urinary Tract Infections (UTIs) in the U.S. For instance,
according to American Urological Association 2016, more than 1 million
catheter-associated UTIs are reported annually in the U.S. and up to 40% of
hospital gram negative bacteremias originate as UTIs annually, which are
treated by antibiotics.
Asia Pacific region is expected
to witness significant growth in the sulfachloropyridazine market due to
involvement of key players in manufacturing antibiotics solely for veterinary
purposes. One of the company named Weifang Premier Animal Pharmaceutical
Industries Co., Ltd, a China-based company also involved in animal husbandry.
They contributes to animal health by manufacturing sulfachloropyridazine sodium
soluble powder as one of the key product in China.
Key players involved in
Sulfachloropyridazine market include Sigma-Aldrich, Inc., Zhengzhou Fuyuan
Chemical Industry Co., Ltd, Santa Cruz Biotechnology, Inc., UBM, Hefei TNJ
Chemical Industry Co., Ltd., AK Scientific Inc., SuZhou Wugan Pharmaceutical
Co., Quimica Alkano, Shanghai Danfan Network Science&Technology Co., Ltd.,
and Ofichem Group.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2263
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment